Windham Capital Partners — 2015 Investments
3 investments dated 2015 · listed companies and verified rows first · show all
HealthtechSan Diego, US
JOSEPH Y. LUCISANO(CHIEF TECHNOLOGY OFFICER)WILLIAM H. MARKLE(PRESIDENT AND CEO)
BoardADAM E. FINE(Director)inSAMUEL V. GOEKJIAN(Director)ROBERT L. ENGLER(Director)ORVILLE G. KOLTERMAN(Director)
Aytu BioPharma is a pharmaceutical company developing treatments for complex central nervous system (CNS) conditions, including major depressive disorder (MDD) and ADHD.
BiotechHealthtechMountain View, US
Joshua Makower(Executive Officer, Director)Stefano Curti(Executive Officer, Director)Yi Li(Director)Ryan Drant(Director)
BoardDavis Yang(Director)John Nehra(Director)
Co-investorsRuvento Ventures Pte Ltd.
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Ryan Sysko(Executive Officer, Director)Suzanne Clough(Executive Officer)Kevin McRaith(President and CEO)Anand Iyer(Chief AI Officer)Chris Bergstrom(Executive Officer)Anand K. Iyer(Executive Officer)
Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementTCP Venture Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.